Navigation Links
Allscripts to Announce Third Quarter 2007 Results on November 8th
Date:10/23/2007

CHICAGO, Oct. 23 /PRNewswire-FirstCall/ -- Allscripts (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, announced today that it will report its earnings for the three and nine months ended September 30, 2007 after the stock market closes on Thursday, November 8, 2007. At 4:30 PM Eastern Standard Time on the same day, Allscripts management will host a conference call and webcast to discuss the Company's earnings and other information.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)

The earnings announcement will be distributed via PR Newswire immediately after the market closes on the afternoon of November 8th. The release will also be available on the Company's website at http://www.allscripts.com. To listen to the conference call broadcast, participants may log onto http://www.allscripts.com. It is recommended that participants log onto the website approximately 15 minutes prior to the start of the conference call to download and install any necessary software. The conference call also can be accessed by dialing (888) 644-5594 and requesting the Allscripts earnings call. A Microsoft Windows Media Player web replay will be available three hours after the conclusion of the call for a period of two weeks at http://www.allscripts.com or by calling (800) 642-1687, ID # 21783504.

(Minimum requirements to listen to the broadcast are: Microsoft Wind
'/>"/>

SOURCE Allscripts
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. OHSU Researchers Announce New Discovery
2. PM announces a new health care order for India
3. Partnership Between Diabetes India And Elsevier Announced
4. US Politicians Urge Movie Moghuls To Add Anti-Smoking Announcements
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... BOSTON, Nov. 21 Innerscope Resea... firm specializing in Emotional Response Measureme...utives who will strengthen the,company,s research...,initiatives. , The three appointments, who...de Geoffrey Gill as Chief Financial Officer and Vi...
(Date:11/21/2008)... , COLD SPRING HARBOR, N.Y. (Nov. 21, 2008) Ho...What can the lamprey immune system tell us about e...ations help with efforts to conserve rare species?...duction, and hereditary diseases? Will studies of... , To answer these and other questions in biolog...
(Date:11/21/2008)... WASHINGTON, Nov. 21 New inventio... with a variety of cognitive disabilities lead ful...ience(R) Corporation. Zimman,presented today at t...ington,DC, a meeting organized by The National C...tion to assist people with disabilities. , ...
(Date:11/21/2008)... Winter viruses may be to blame, study suggests ...The season of a baby,s birth may help predict that..., Babies born in autumn -- about four months befo...a 30 percent increased risk of asthma compared to ...study in the first December issue of the American...
Breaking Medicine News(10 mins):Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:A new world of research possibilities with 'Emerging Model Organisms' 2Health News:New Applications for Cognitive Training 2Health News:Autumn Babies More Prone to Asthma 2Health News:Autumn Babies More Prone to Asthma 3
...s of vitamin C notwithstanding, British researcher...! It is now said that vitamin C reverses pre eclam...e leading contributors to complications in childbi...n lead onto eclampsia which, when left untreated, ...
...hat causes infectious mononucleosis, Epstein-Barr ...o the development of Hodgkin's disease. But no one...BV and Hodgkin's survival, according to researcher... from Northern California Cancer Center in Union C...
...d on more than 1600 women reveals that parathyroid...ne density and cut the risk of fractures in them. ...ium levels in the body. The new aspect of th...ures has opened up the prospect of the hormone bei...
...n from Mayo Foundation in Rochester, Minnesota has...ble metal stents in the digestive tract of people ...ese patients commonly suffer from obstructions and...ke difficulty in swallowing, if the block is in th...
Other Medicine News:
(Date:11/21/2008)... -- Ikaria Holdings, Inc. today announced that it ...New Jersey Technology Council (NJTC), a 1,200-memb...support, networking opportunities, information and...rs. Ikaria earned the award based on criteria incl... provision. , , "We are delighted that the ...
(Date:11/20/2008)...ire/ -- New Jersey American Water has lifted the ...rs in the following municipalities in Middlesex, S...ounty , , , Dunellen , Ediso...South Plainfield , , , , Somerset C...idgewater , Green Brook , Hillsborou...
(Date:11/20/2008)...20 Arpida (SWX:,ARPN) a...ory Committee of the,U.S. Food and Drug Administr...l of intravenous iclaprim, an antibiotic currently...h complicated skin and skin structure infections,...sistant Staphylococcus,aureus (MRSA). , Ar...
(Date:11/20/2008)...re-FirstCall/ -- Duska Therapeutics,Inc., (OTC B...submitted its,pivotal Phase 3 ATPace clinical tri...ssessment (SPA) procedure with the U.S. Food and D...uring an agreement with the FDA, Duska intends to ...cebo-controlled and randomized Phase 3,clinical t...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Mindray to Attend 2007 RSNA Conference in Chicago 6781 1Mindray to Attend 2007 RSNA Conference in Chicago 6781 2Mindray to Attend 2007 RSNA Conference in Chicago 6781 3Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 6779 1Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 6779 2Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 1Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 2Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 3Danaher Closes Subsequent Offering Period for Tektronix 3B Acquires Over 90 25 of TEK Shares 6775 1Danaher Closes Subsequent Offering Period for Tektronix 3B Acquires Over 90 25 of TEK Shares 6775 2
...s TNF-alpha Production Through Inhibition,of PDE-4...ire/ -- Anacor,Pharmaceuticals, a privately held p... from its placebo-controlled Phase 1 trial of,AN27...gation for,the treatment of psoriasis. The trial s...omparable to existing topical,treatments for psori...
...k, June 06, 2007 /PRNewswire-FirstCall/,-- XTL Bio...ompleted the analysis of results from a Phase I cl...c Hepatitis C. This Phase I,trial was a placebo co... evaluated the safety, tolerability and antiviral ... The study enrolled 56,patients into seven cohorts...
Other Medicine Technology:Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2XTL Provides Update on Phase I Clinical Trial of XTL-2125 2XTL Provides Update on Phase I Clinical Trial of XTL-2125 3
Inquire
...are is easy to configure for gravimetric calibrati...ndard method or enter your own parameters (number ... QualiTrace automatically manages the calibration ...from the balance to the software, which establishe...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile
Reagent Basin, 60mL, 5/Box
Medicine Products: